scholarly journals Impact of an Evidence-Based Bundle Intervention in the Quality-of-Care Management and Outcome of Staphylococcus aureus Bacteremia

2013 ◽  
Vol 57 (9) ◽  
pp. 1225-1233 ◽  
Author(s):  
L. E. Lopez-Cortes ◽  
M. D. del Toro ◽  
J. Galvez-Acebal ◽  
E. Bereciartua-Bastarrica ◽  
M. C. Farinas ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Quality Of Care ◽  
Care Management ◽  
Evidence Based ◽  
Staphylococcus Aureus Bacteremia

Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis

Infection ◽  
2016 ◽  
Vol 45 (1) ◽  
pp. 83-91 ◽  
Author(s):  
Miki Nagao ◽  
Masaki Yamamoto ◽  
Yasufumi Matsumura ◽  
Isao Yokota ◽  
Shunji Takakura ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Quality Of Care ◽  
Evidence Based ◽  
Staphylococcus Aureus Bacteremia

scholarly journals Staphylococcus aureus Bacteremia (SAB) Management in a Large Metropolitan Integrated Health Region: Quality of Care Determinants (QoCD)

2017 ◽  
Vol 4 (suppl_1) ◽  
pp. S557-S558 ◽  
Author(s):  
John Lam ◽  
Stephen Robinson ◽  
Daniel Gregson ◽  
Ranjani Somayaji ◽  
Lisa Welikovitch ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Quality Of Care ◽  
Health Region ◽  
Staphylococcus Aureus Bacteremia ◽  
Integrated Health

scholarly journals An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia

2017 ◽  
Vol 65 (2) ◽  
pp. 194-200 ◽  
Author(s):  
Eric Wenzler ◽  
Fei Wang ◽  
Debra A. Goff ◽  
Beth Prier ◽  
John Mellett ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Quality Of Care ◽  
Staphylococcus Aureus Bacteremia

scholarly journals Disparity in Quality of Infectious Disease vs Addiction Care Among Patients With Injection Drug Use–Associated Staphylococcus aureus Bacteremia

2019 ◽  
Vol 6 (7) ◽  
Author(s):  
David Phillip Serota ◽  
Emily D Niehaus ◽  
Marcos C Schechter ◽  
Jesse T Jacob ◽  
Jeb Jones ◽  
...  
Keyword(s):  
Infectious Disease ◽  
Staphylococcus Aureus ◽  
Drug Use ◽  
Injection Drug Use ◽  
Injection Drug ◽  
Evidence Based ◽  
High Quality ◽  
Staphylococcus Aureus Bacteremia ◽  
Addiction Care

Abstract Evidence-based interventions for Staphylococcus aureus bacteremia (SAB) are well known, but it is unclear how they are implemented among patients with injection drug use–associated (IDU) SAB. Of 46 patients with IDU-SAB identified, all received high-quality SAB management; however, few received appropriate recognition or treatment of their underlying substance use disorder.

scholarly journals 291. Impact of Surveillance and Offered Infectious Diseases Consults for Staphylococcus aureus Bacteremia on Quality of Care Indicators

2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S145-S145
Author(s):  
Khushali Jhaveri ◽  
Sheena Ramdeen
Keyword(s):  
Staphylococcus Aureus ◽  
Quality Of Care ◽  
Infectious Diseases ◽  
Blood Cultures ◽  
Lower Mortality ◽  
Duration Of Therapy ◽  
Staphylococcus Aureus Bacteremia ◽  
Source Of Infection

Abstract Background Staphylococcus aureus bacteremia (SAB) remains the leading cause of bloodstream infections and is associated with 20–40% mortality. Past studies demonstrated that Infectious Diseases (ID) consultation is associated with better adherence to quality of care indicators (QCIs), including follow-up blood cultures, echocardiography, early source control, and appropriate choice and duration of antibiotics. A 2014 quality improvement project at Medstar Washington Hospital Center (MWHC) by Narsana et al. showed significantly better adherence to SAB QCIs among patients with ID consults and a non-significant trend towards lower mortality. In 2015, MWHC instituted a policy advocating ID consultation for all SAB patients, and active surveillance was performed by the ID Section to offer prompt consults prospectively. Our study aimed to assess the impact of this policy and the proactively offered ID consults on adherence to SAB QCIs and mortality rates amongst patients with SAB with and without ID consults. Methods We retrospectively reviewed 557 patients diagnosed with SAB between July 1st, 2015 - June 30th, 2018. Data included follow-up blood cultures, echocardiography, presence of a focal source of infection, use of appropriate antibiotics, measurement of vancomycin levels, duration of therapy, death during hospitalization, and presence of an ID consultation. Chi-Square and Fisher exact tests, and t-test and Wilcoxon rank sum test were used to analyze categorical and continuous variables, respectively. Results A total of 513 patients were included in the analysis, 88% (n=453) of whom had ID consultations. Patients with ID consultations were more likely to have a focal source of infection (84% vs. 50%, p < 0.0001), echocardiography (97% vs. 56%, p < 0.0001), use of a beta-lactam antibiotic for methicillin-susceptible S. aureus (90% vs 65%, p < 0.0001), and a longer duration of therapy (33 vs 9 days, p< 0.0001). Mortality was lower among patients with ID consults (16% vs. 23%, p=0.1495), but the difference was not statistically significant. Table 1 Conclusion Our study demonstrates that ID consultation is associated with better adherence to SAB QCIs, with a trend towards lower mortality. Hospital systems should support mandatory ID consultation for patients with Staphylococcus aureus bacteremia. Disclosures All Authors: No reported disclosures

scholarly journals 257. Staphylococcus aureus Bacteremia: Does Intravenous Drug Use Impact Quality of Care and Clinical Outcomes?

2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S127-S128
Author(s):  
Kristen McClellan ◽  
Cami Hilsendager ◽  
Strnad Luke
Keyword(s):  
Staphylococcus Aureus ◽  
Quality Of Care ◽  
Drug Use ◽  
Clinical Outcomes ◽  
Intravenous Drug ◽  
Standards Of Care ◽  
Intravenous Drug Use ◽  
Staphylococcus Aureus Bacteremia ◽  
Device Infection

Abstract Background Individuals with intravenous drug use (IDU) have higher risk for Staphylococcus aureus bacteremia (SAB) and increased management complexity. The goal of this study was to compare differences in SAB characteristics, adherence to standard of care metrics, and clinical outcomes in those with and without IDU. Methods A retrospective chart review was conducted on cases of SAB between January 1, 2016 and December 31, 2017 at a 500-bed teaching hospital. Inclusion criteria was age > 18 years and ≥ one blood culture positive for S. aureus. Patients were excluded if they transferred hospitals, had care withdrawn or died within 48 hours of diagnosis or had a ventricular assist device infection. Records were reviewed for substance use, SAB characteristics, standards of care, and outcomes. Data were analyzed using SPSS software. The study was approved by the Institutional Review Board. Results In 248 patients with SAB, 28.2% had documented IDU. Median age was 37 (IDU) and 57 (non-IDU). In the IDU group, 75.7% had the formal diagnosis of opioid use disorder and 78.9% of stimulant use disorder. IDU was associated with hepatitis C and houselessness while non-IDU was associated with diabetes, hemodialysis, and cancer. Those with IDU had higher rates of MRSA, endocarditis, and spinal infections, but did not have higher rates of polymicrobial infections or venous thrombosis. There was no difference in appropriate repeat blood cultures, antibiotic management, and ID consultation. Length of stay and against medical advice (AMA) discharges were higher in those with IDU. There was no difference in 90-day recurrence or readmission, but 90-day mortality was higher in the non-IDU group. Conclusion There was no difference in adherence to SAB quality of care metrics between groups with and without IDU. Despite the IDU group being younger with fewer comorbidities, 90-day readmissions were not different between groups. This bears further analysis but may represent the influence of therapy completion, AMA discharges, and unmeasured social determinants of health. Disclosures All Authors: No reported disclosures

Long-Term Outcome and Quality of Care of Patients with Staphylococcus aureus Bacteremia

2004 ◽  
Vol 23 (3) ◽  
pp. 157-162 ◽  
Author(s):  
G. F�tkenheuer ◽  
M. Preuss ◽  
B. Salzberger ◽  
N. Schmei�er ◽  
O. A. Cornely ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Quality Of Care ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Staphylococcus Aureus Bacteremia

scholarly journals 722Infectious Diseases Consultation Increases Adherence with Quality of Care Indicators for Management of Staphylococcus aureus Bacteremia

2014 ◽  
Vol 1 (suppl_1) ◽  
pp. S204-S204
Author(s):  
Manjit Dhillon ◽  
Kaushal Shah ◽  
Muhammad Salman Ashraf ◽  
Hao Nguyen ◽  
Paul Cook
Keyword(s):  
Staphylococcus Aureus ◽  
Quality Of Care ◽  
Staphylococcus Aureus Bacteremia
Sign in / Sign up

Export Citation Format

Share Document